ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,821, issued on Nov. 25, was assigned to MBD Co. LTD. (Suwon-si, South Korea).
"Quinoline compound and use thereof" was invented by Bosung Ku (Yongin-si, South Korea), Gun Hwa Kim (Daejeon, South Korea), Sin Hyoung Hong (Daejeon, South Korea), Min Ji Lee (Daejeon, South Korea), Ji Hoon Lee (Daegu, South Korea) and Sang-Hyun Lee (Gyeonggi-do, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel quinoline compound and a use thereof and to a novel quinoline compound exhibiting CYP4A inhibition activity and a use thereof for preventing, alleviating, treating a metabolic disease. The compound disclosed in the...